| Nome del prodotto |
2'H-androst-2-eno[3,2-c]pirazolo-17-olo,17-metil-, (5a,17b)- |
| Sinonimi |
2'H-5a-androst-2-eno[3,2-c]pirazolo-17b-olo, 17-metil- (8CI); Ciclopenta[7,8]fenantro[2,3-c]pirazolo-1-olo,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-esadecaidro-1,10a,12a-trimetil-(6CI,7CI); 17-metil-5a-androstano[3,2-c]pirazolo-17b-olo; 17-metil-pirazolo[4',3':2,3]-5a-androstan-17b-olo; 17a-metil-17b-idrossi-5a-androstano(3,2-c)pirazolo; 17b-idrossi-17-metil-5a-androstano[3,2-c]pirazolo; 17b-idrossi-17a-metil-5a-androstano[3,2-c]pirazolo; Anabol; Androstanazolo; Androstanazolo; Androstanazolestanazolo; Estazol; NSC233046; Stanabolico; Stanazolol; Stanozolol; Stromba; Strombaject; Tevabolin; Vincere 14833; Winstroid; Winstrol; Deposito di Winstrol; Winstrol V |
| Nome inglese |
2'H-Androst-2-eno[3,2-c]pyrazol-17-ol,17-methyl-, (5a,17b)-;2'H-5a-Androst-2-eno[3,2-c]pyrazol-17b-ol, 17-methyl- (8CI); Cyclopenta[7,8]phenanthro[2,3-c]pyrazol-1-ol,1,2,3,3a,3b,4,5,5a,6,7,10,10a,10b,11,12,12a-hexadecahydro-1,10a,12a-trimethyl-(6CI,7CI); 17-Methyl-5a-androstano[3,2-c]pyrazol-17b-ol; 17-Methyl-pyrazolo[4',3':2,3]-5a-androstan-17b-ol; 17a-Methyl-17b-hydroxy-5a-androstano(3,2-c)pyrazole; 17b-Hydroxy-17-methyl-5a-androstano[3,2-c]pyrazole; 17b-Hydroxy-17a-methyl-5a-androstano[3,2-c]pyrazole; Anabol; Androstanazol; Androstanazole; Androstanazolestanazol; Estazol; NSC233046; Stanabolic; Stanazolol; Stanozolol; Stromba; Strombaject; Tevabolin; Win 14833; Winstroid; Winstrol; Winstrol Depot; Winstrol V |
| Formula molecolare |
C21H32N2O |
| Peso Molecolare |
328.55 |
| Numero CAS |
302-96-5 |
| Struttura molecolare |
|
| Densità |
1.129g/cm3 |
| Punto di ebollizione |
490.8°Cat760mmHg |
| Punto d'infiammabilità |
250.7°C |
| Sicurezza Descrizione |
x." target="_blank">Human systemic effects by ingestion: jaundice. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx.:;
|
|